tradingkey.logo

Champions Oncology Inc

CSBR
查看详细走势图
6.550USD
+0.020+0.31%
收盘 02/06, 16:00美东报价延迟15分钟
90.96M总市值
36.04市盈率 TTM

Champions Oncology Inc

6.550
+0.020+0.31%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.31%

5天

-10.40%

1月

-0.91%

6月

0.00%

今年开始到现在

-5.21%

1年

-38.56%

查看详细走势图

TradingKey Champions Oncology Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Champions Oncology Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名81/392位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价12.00。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Champions Oncology Inc评分

相关信息

行业排名
81 / 392
全市场排名
205 / 4521
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Champions Oncology Inc亮点

亮点风险
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
业绩增长期
公司处于发展阶段,最新年度总收入56.94M美元
业绩转盈
公司业绩转盈,最新年度盈利美元
估值高估
公司最新PE估值36.04,处于3年历史高位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值334.61K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.11

分析师目标

根据 1 位分析师
买入
评级
12.000
目标均价
+83.77%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Champions Oncology Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Champions Oncology Inc简介

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
公司代码CSBR
公司Champions Oncology Inc
CEOBrainin (Robert)
网址https://championsoncology.com
KeyAI